FI852221A0 - Saosom kardiovaskulaera laekemedel anvaendbara dihydropyridiner. - Google Patents

Saosom kardiovaskulaera laekemedel anvaendbara dihydropyridiner.

Info

Publication number
FI852221A0
FI852221A0 FI852221A FI852221A FI852221A0 FI 852221 A0 FI852221 A0 FI 852221A0 FI 852221 A FI852221 A FI 852221A FI 852221 A FI852221 A FI 852221A FI 852221 A0 FI852221 A0 FI 852221A0
Authority
FI
Finland
Prior art keywords
dihydropyridiner
saosom
anvaendbara
cardiovascular
ceiling
Prior art date
Application number
FI852221A
Other languages
English (en)
Other versions
FI852221L (fi
Inventor
J E Arrowsmith
Simon Fraser Campbell
Peter Edward Cross
R P Dickinson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI852221A0 publication Critical patent/FI852221A0/fi
Publication of FI852221L publication Critical patent/FI852221L/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FI852221A 1984-06-07 1985-06-03 Saosom kardiovaskulaera laekemedel anvaendbara dihydropyridiner. FI852221L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848414518A GB8414518D0 (en) 1984-06-07 1984-06-07 Therapeutic agents

Publications (2)

Publication Number Publication Date
FI852221A0 true FI852221A0 (fi) 1985-06-03
FI852221L FI852221L (fi) 1985-12-08

Family

ID=10562060

Family Applications (1)

Application Number Title Priority Date Filing Date
FI852221A FI852221L (fi) 1984-06-07 1985-06-03 Saosom kardiovaskulaera laekemedel anvaendbara dihydropyridiner.

Country Status (14)

Country Link
US (1) US4647565A (fi)
EP (1) EP0168151A1 (fi)
JP (1) JPS6133185A (fi)
KR (1) KR860000286A (fi)
AU (1) AU554571B2 (fi)
DK (1) DK253585A (fi)
ES (1) ES8704480A1 (fi)
FI (1) FI852221L (fi)
GB (1) GB8414518D0 (fi)
GR (1) GR851380B (fi)
HU (1) HUT37933A (fi)
IL (1) IL75427A0 (fi)
PL (1) PL253820A1 (fi)
PT (1) PT80596B (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4568677A (en) * 1983-07-23 1986-02-04 Pfizer Inc. 2-(4-Pyrimidone alkoxyalkyl) dihydropyridine anti-ischaemic and antihypertensive agents
GR851819B (fi) * 1984-08-17 1985-11-26 Wyeth John & Brother Ltd
PT100905A (pt) * 1991-09-30 1994-02-28 Eisai Co Ltd Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
US6976162B1 (en) * 2000-06-28 2005-12-13 Intel Corporation Platform and method for establishing provable identities while maintaining privacy
EP2147679B1 (en) 2001-07-25 2014-06-25 Raptor Pharmaceutical, Inc. Compositions for blood-brain barrier transport
DK1889198T3 (da) 2005-04-28 2015-02-09 Proteus Digital Health Inc Farma-informatiksystem
WO2008036682A2 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
DK2398500T3 (da) 2009-02-20 2019-05-13 2 Bbb Medicines B V Glutathion-baseret lægemiddelafgivelsessystem
IL255113B (en) 2009-05-06 2022-09-01 Laboratory Skin Care Inc Preparations for administration through the skin that include complexes of an active substance with calcium phosphate and methods of using them
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK140695C (da) * 1976-05-07 1980-05-12 Synthelabo Analogifremgangsmaade til fremstilling af 2,4-diamino-6,7-dimethoxyquinazolinderivater eller syreadditionssalte heraf
DK159079A (da) * 1978-05-18 1979-11-19 Pfizer Fremgangsmaade til fremstilling af derivater af 4-amino-2-piperidinoquinazolin eller syreadditionssalte deraf
CS228917B2 (en) * 1981-03-14 1984-05-14 Pfizer Method of preparing substituted derivatives of 1,4-dihydropyridine
DK161312C (da) * 1982-03-11 1991-12-09 Pfizer Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
DE3363743D1 (en) * 1982-07-22 1986-07-03 Pfizer Ltd Dihydropyridine anti-ischaemic and antihypertensive agents

Also Published As

Publication number Publication date
US4647565A (en) 1987-03-03
JPS6133185A (ja) 1986-02-17
KR860000286A (ko) 1986-01-27
FI852221L (fi) 1985-12-08
HUT37933A (en) 1986-03-28
AU554571B2 (en) 1986-08-28
ES543997A0 (es) 1987-04-01
EP0168151A1 (en) 1986-01-15
PT80596A (en) 1985-07-01
PL253820A1 (en) 1986-07-01
GB8414518D0 (en) 1984-07-11
PT80596B (en) 1987-04-21
AU4334785A (en) 1985-12-12
ES8704480A1 (es) 1987-04-01
DK253585D0 (da) 1985-06-06
IL75427A0 (en) 1985-10-31
GR851380B (fi) 1985-11-25
DK253585A (da) 1985-12-08

Similar Documents

Publication Publication Date Title
NO165939C (no) Brannalarmsystem.
NO852548L (no) Brannalarmsystem.
FI83882B (fi) Foerfarande foer framstaellning av blodlevring haemmande proteiner.
FI860048A0 (fi) Framstaellning av extruderad laettformprofil.
FI853478L (fi) Foerfarande foer framstaellning av fenylalkylfoereningar.
DE3578342D1 (de) Biegsame decke.
FI850174A0 (fi) Foerfarande foer framstaellning av (5-het-)metylenpenemer.
FI840174A (fi) Foerfarande foer optisk maetning av laongstraeckta stycken.
FI870580A (fi) Saosom kardiovaskulaera laekemedel anvaendbara 3-alkoxi-2-aminopropylaminer.
FI852221L (fi) Saosom kardiovaskulaera laekemedel anvaendbara dihydropyridiner.
FI80896B (fi) Foerfarande foer framstaellning av fenolskum.
FI840758A (fi) Anlaeggning foer utnyttjande av vaermeenergi alstrad av en bastuugn.
FI841768A0 (fi) Anordning foer rullning av traedstammar.
FI854632A0 (fi) Kvaevederivat av oxofoereningar.
FI841518A0 (fi) Foerfarande foer framstaellning av stabila injektionspreparat av indolylalifatiska syraderivat.
FI841368A0 (fi) Anordning foer jaemning av sandskikt.
FI840678A (fi) Minnesapparat foer dosering av laekemedel.
FI841198A (fi) Nytt foerfarande foer framstaellning av - glutamyltaurin.
FI80875B (fi) Framstaellning av isobutyrylfluorid.
FI840552A (fi) Foerfarande foer framstaellning av formdelar.
FI841802A0 (fi) Anordning foer foerflyttning av skivpaket.
FI840251A (fi) Anlaeggning foer optimering av papperstillverkning.
FI840038A (fi) Foerfarande foer avledande av foerbraenningsgaser.
FI841366A0 (fi) Foerfarande foer kokning av foerhydrolyscellulosa.
FI841478A0 (fi) Foerfarande foer framstaellning av en kulformad kopplingsdel foer vaetskeavspaerrningsorgan.

Legal Events

Date Code Title Description
FA Application withdrawn

Owner name: PFIZER CORPORATION